During the past decade, Ospedale di Castelfranco Veneto - Ematologia conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Ospedale di Castelfranco Veneto - Ematologia" are "Aggressive Non-Hodgkin Lymphoma" (1 trials), "Classical Hodgkin Lymphoma" (1 trials), "Diffuse Large B Cell Lymphoma" (1 trials) and "Hodgkin Lymphoma" (1 trials). Many other conditions were trialed in "Ospedale di Castelfranco Veneto - Ematologia" in a lesser frequency.

Most popular intervention types in "Ospedale di Castelfranco Veneto - Ematologia" are "Drug" (3 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Bleomycin" (1 trials), "Cyclophosphamide" (1 trials), "Dacarbazine" (1 trials), "Doxorubicin" (1 trials) and "Etoposide" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ospedale di Castelfranco Veneto - Ematologia" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Ospedale di Castelfranco Veneto - Ematologia". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Ospedale di Castelfranco Veneto - Ematologia, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Ospedale di Castelfranco Veneto - Ematologia, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".